[{"address1": "11400 West Olympic Boulevard", "address2": "Suite 200", "city": "Los Angeles", "state": "CA", "zip": "90064", "country": "United States", "phone": "310 651 8041", "website": "https://www.immixbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ilya  Rachman M.B.A., M.D., MBA, Ph.D.", "age": 51, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 712500, "exercisedValue": 0, "unexercisedValue": 120332}, {"maxAge": 1, "name": "Mr. Gabriel  Morris B.A.", "age": 37, "title": "CFO & Director", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 712500, "exercisedValue": 0, "unexercisedValue": 461582}, {"maxAge": 1, "name": "Dr. Graham  Ross FFPM, M.D.", "age": 64, "title": "Chief Medical Officer & Head of Clinical Development", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 88593, "exercisedValue": 0, "unexercisedValue": 5100}, {"maxAge": 1, "name": "Mr. Sean  Senn J.D., M.B.A., M.Sc., MBA, MSc", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vladimir P. Torchilin D.Sc., MSE, Ph.D.", "age": 77, "title": "Scientific Co-Founder", "yearBorn": 1947, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Marks MBBS, Ph.D.", "title": "Chief Medical Officer of Cell Therapy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mel  Davis-Pickett", "title": "Head of CMC Technical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.43, "open": 3.48, "dayLow": 3.25, "dayHigh": 3.66, "regularMarketPreviousClose": 3.43, "regularMarketOpen": 3.48, "regularMarketDayLow": 3.25, "regularMarketDayHigh": 3.66, "payoutRatio": 0.0, "beta": 0.225, "forwardPE": -6.563636, "volume": 1163895, "regularMarketVolume": 1163895, "averageVolume": 357606, "averageVolume10days": 753810, "averageDailyVolume10Day": 753810, "bid": 3.58, "ask": 3.65, "bidSize": 2, "askSize": 3, "marketCap": 119258208, "fiftyTwoWeekLow": 1.34, "fiftyTwoWeekHigh": 3.66, "allTimeHigh": 8.68, "allTimeLow": 0.68, "fiftyDayAverage": 2.3407, "twoHundredDayAverage": 2.15338, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 93496000, "profitMargins": 0.0, "floatShares": 19376811, "sharesOutstanding": 33035515, "sharesShort": 598715, "sharesShortPriorMonth": 454735, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.018099999, "heldPercentInsiders": 0.35708, "heldPercentInstitutions": 0.08456001, "shortRatio": 1.51, "shortPercentOfFloat": 0.0277, "impliedSharesOutstanding": 33035515, "bookValue": 0.164, "priceToBook": 22.012194, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -23126540, "trailingEps": -0.77, "forwardEps": -0.55, "enterpriseToEbitda": -3.952, "52WeekChange": 1.1488094, "SandP52WeekChange": 0.16625166, "quoteType": "EQUITY", "currentPrice": 3.61, "targetHighPrice": 8.0, "targetLowPrice": 8.0, "targetMeanPrice": 8.0, "targetMedianPrice": 8.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 11637945, "totalCashPerShare": 0.404, "ebitda": -23659982, "totalDebt": 1042802, "quickRatio": 1.163, "currentRatio": 1.231, "debtToEquity": 22.411, "returnOnAssets": -0.66849, "returnOnEquity": -1.6204, "freeCashflow": -4037955, "operatingCashflow": -12507206, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IMMX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fiftyDayAverageChangePercent": 0.5422737, "twoHundredDayAverageChange": 1.45662, "twoHundredDayAverageChangePercent": 0.6764343, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-12-16", "cryptoTradeable": false, "shortName": "Immix Biopharma, Inc.", "longName": "Immix Biopharma, Inc.", "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755288000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.77, "epsForward": -0.55, "epsCurrentYear": -0.675, "priceEpsCurrentYear": -5.348148, "fiftyDayAverageChange": 1.2693, "corporateActions": [], "postMarketTime": 1761348786, "regularMarketTime": 1761336001, "exchange": "NCM", "messageBoardId": "finmb_417356223", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "regularMarketChangePercent": 5.24781, "regularMarketPrice": 3.61, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1639665000000, "postMarketChangePercent": 1.38505, "postMarketPrice": 3.66, "postMarketChange": 0.0500002, "regularMarketChange": 0.18, "regularMarketDayRange": "3.25 - 3.66", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 357606, "fiftyTwoWeekLowChange": 2.27, "fiftyTwoWeekLowChangePercent": 1.6940298, "fiftyTwoWeekRange": "1.34 - 3.66", "fiftyTwoWeekHighChange": -0.05000019, "fiftyTwoWeekHighChangePercent": -0.013661254, "fiftyTwoWeekChangePercent": 114.88094, "displayName": "Immix Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-10-25"}]